Skip to content
Cryptos: 603Market Cap: $3.44T 1.8%24h Vol: $149.01BDominance: BTC 46.9% ETH 8.6%
Open Tradzy

Big move · Germany stocks

Abbott Laboratories (ABL) rises 5.5% to €102.80

Its biggest one-day rise in 4 months, on 2.8 times its recent average volume.

Published 4 November 2026 · Written from Tradzy's price and volume data

Close
€102.80
On the day
+5.5%
Volume
2.8× average
vs 52-week high
−8.7%

Abbott Laboratories closing prices

€80.00€90.00€100.00Jul '26Jul '26Aug '26Sep '26Oct '26Nov '26€102.80

The last 90 closes up to 4 November 2026. The live chart is on the ABL page.

What happened

Abbott Laboratories (ABL) closed at €102.80 on 4 November 2026, up 5.5% from €97.48 the session before.

It was ABL's biggest one-day rise in 4 months. It was the fifth higher close in a row. Over 5 sessions the price is up 11.6%, and over 20 sessions it is up 16.7%.

The close is 8.7% below the highest close of the past year (€112.56 on 18 Nov 2025) and 46.9% above the lowest (€69.96 on 11 May 2026).

Trading was heavy: volume was 2.8 times its average of the sessions before.

Across the 13 FRANKFURT stocks we track, 8 closed higher and 4 closed lower that day, with a median change of +1.48%. ABL's change was +5.5%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous close€97.48
Close€102.80
Change on the day+5.46%
Change over 5 sessions+11.59%
Change over 20 sessions+16.69%
Volume461
Average volume, up to 20 sessions before162
Volume against that average2.8 times
Highest close in the past year€112.56 (18 Nov 2025)
Lowest close in the past year€69.96 (11 May 2026)

The full chart and history are on Abbott Laboratories (ABL). More from this market: FRANKFURT news today.

More FRANKFURT moves on 4 November 2026

Want a plan for ABL? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.